Universal Health Services (UHS)
(Delayed Data from NYSE)
$224.66 USD
-4.35 (-1.90%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $224.60 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$224.66 USD
-4.35 (-1.90%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $224.60 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Zacks News
Zacks.com featured highlights include Universal Health, EnerSys, Kinross Gold and Unum
by Zacks Equity Research
Universal Health, EnerSys, Kinross Gold and Unum have been highlighted in this Screen of The Week article.
DENTSPLY SIRONA Stock May Gain on the Launch of Primescan 2
by Zacks Equity Research
XRAY introduces its new-generation intraoral scanner, Primescan 2, to provide effective and efficient care and comfort to patients.
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
by Zacks Equity Research
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
Reasons to Retain Revvity Stock in Your Portfolio for Now
by Zacks Equity Research
RVTY's strong product portfolio raises optimism about the stock.
4 Bargain Stocks With Low Price-to-Cash Flow to Record September Gains
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. UHS, ENS, KGC & UNM boast a low P/CF ratio.
HealthEquity Stock May Gain From Its Latest Partnership With Paytient
by Zacks Equity Research
HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.
Intuitive Surgical Gains 40.5% Year to Date: What's Driving the Stock?
by Zacks Equity Research
ISRG's shares gain on the back of strength in da Vinci surgical system.
BD Stock Falls After Acquisition of Edwards' Critical Care Group
by Zacks Equity Research
BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
by Zacks Equity Research
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat
by Zacks Equity Research
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
Elevance Health Stock Has More to Offer: Should You Hold on Tight?
by Zacks Equity Research
In the commercial category, an increase in individual as well as employer group fee-based memberships will continue supporting ELV's medical membership numbers.
AngioDynamics Stock Falls Despite CE Mark for Auryon System
by Zacks Equity Research
ANGO's Auryon Atherectomy System earns CE Mark, which expands its European market reach and enhances PAD treatment with advanced laser technology.
Ensign Adds 8 Facilities in Kansas & Colorado to Expand Footprint
by Zacks Equity Research
The acquisition deals increase ENSG's portfolio to encompass 323 healthcare operations spanning 14 states.
Are Investors Undervaluing Universal Health Services (UHS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
by Zacks Equity Research
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
by Zacks Equity Research
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
Greenville Center to Boost CAH Stock's at-Home Solution Business
by Zacks Equity Research
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI
by Zacks Equity Research
FEMY's eco-friendly FemVue MINI receives CE Mark and Health Canada approval, advancing sustainable fallopian tube assessment technology in Europe and Canada.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
by Zacks Equity Research
QDEL's strong product portfolio raises optimism about the stock.
Encompass Health Stock Rises 39.4% YTD: Should You Buy Now?
by Zacks Equity Research
To meet the increasing demand for its services, EHC is expected to continue adding beds.
Here's Why Universal Health Services (UHS) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data
by Zacks Equity Research
DCTH's study of the CHEMOSAT Hepatic Delivery System shows that the device significantly boosts survival rates in uveal melanoma patients with liver metastases, outperforming systemic therapies.
DaVita Rallies 44% Year to Date: What's Driving the Stock?
by Zacks Equity Research
DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Centene Shifts an AcariaHealth Facility to Shelby Township
by Zacks Equity Research
The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.